Amgen (AMGN) Current Assets (2009 - 2026)

Amgen has reported Current Assets for 18 years, with the latest figure at $35.0 billion in Q2 2026.

• On a quarterly basis, Current Assets rose 30.77% year-over-year to $35.0 billion in Q2 2026; TTM through Jun 2026 was $35.0 billion, a 30.77% increase from a year earlier, with the FY2025 full-year figure at $29.1 billion, changed 0.09% from the prior year.
• Current Assets was $35.0 billion for Q2 2026 at Amgen, up from $31.5 billion in the prior quarter.
• The five-year high for Current Assets was $48.5 billion in Q3 2023, with the low at $18.5 billion in Q1 2022.
• Average Current Assets over 5 years is $30.2 billion, with a median of $28.0 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Current Assets soared 145.21% in 2023, then sank 44.79% in 2024.
• Over 5 years, Current Assets stood at $22.2 billion in 2022, then jumped by 36.72% to $30.3 billion in 2023, then dropped by 4.29% to $29.0 billion in 2024, then rose by 0.09% to $29.1 billion in 2025, then climbed by 20.32% to $35.0 billion in 2026.
• The last three Current Assets figures came in at $35.0 billion (Q2 2026), $31.5 billion (Q1 2026), and $29.1 billion (Q4 2025), per Business Quant data.